Categories
News

Fantastic News: CESPE in the driving seat of €41 million European PharmECO Flagship project.

We are thrilled to announce that CESPE will be coordinating a groundbreaking €41 million flagship project, PharmECO – Advancing Safe and Sustainable by Design Practices in Pharmaceutical Manufacturing, of which the proposal has now officially been approved! This pioneering initiative, co-funded under the Innovative Health Initiative (IHI JU Call 4, Topic 6), aims to revolutionize pharmaceutical manufacturing by (i) implementing cutting-edge, sustainable, and scalable manufacturing technologies, and (ii) establishing harmonized environmental sustainability assessment systems for pharmaceuticals and biopharmaceuticals.

To achieve the ambitious goals of this project, 7 CESPE research groups will collaborate with 30 esteemed international institutes, including universities, research institutes, governmental bodies, SMEs, and major pharmaceutical companies.

PharmECO is set to kick off on October 1st, 2024.

CESPE groups involved:

  • Prof. Jo Dewulf – Sustainable Systems Engineering (STEN) research group; Faculty of Bioscience Engineering
  • Prof. Chris Stevens – Synthesis, Bioresources and Bio-organic Chemistry Research Group (SynBioC); Faculty of Bioscience Engineering
  • Prof. Ashish Kumar – Pharmaceutical Engineering Research Group; Faculty of Pharmaceutical Sciences 
  • Prof. Thomas De Beer – Laboratory of Pharmaceutical Process Analytical Technology Faculty of Pharmaceutical Sciences 
  • Prof. Delphine Desmedt Department of Public Health and Primary Care; Faculty of Medicine and Health Sciences
  • Prof. Paul van Liedekerke – BionamiX Research Unit, Department of Data analysis and mathematical modelling,  Faculty of Bioscience Engineering
  • Prof. Jan Verwaeren – KERMIT research unit, Department of Data analysis and mathematical modelling Faculty of Bioscience Engineering

Looking Ahead:

As we embark on this exciting journey, we are committed to driving innovations that will not only advance pharmaceutical manufacturing but also contribute to a more sustainable future. Stay tuned for updates on our progress and the incredible developments we will bring to the industry.

For more information, please contact sarah.costers@ugent.be

Other team members

Other research groups